Apollo Hospitals Q3FY19 PAT grew by 29%

Declares Proton Cancer Centre launch
Report by: 
10 Feb 2019

Apollo Hospitals Q3FY19 PAT grew by 29% to Rs. 869 million. Q3FY19 Standalone Revenues grew 17% to Rs. 21,690 million compared to Rs. 18,561 million in Q3FY18, aided by SAP growth of 18% and Healthcare services growth of 16% YoY. HC services growth of 16% YoY was led by new hospitals which reported 25% YoY Revenue growth while existing hospitals grew 14% YoY. EBITDA was at Rs. 2,679 million in Q3FY19 as against Rs. 2,211 million in Q3FY18 a YoY growth of 21%. PAT grew by 29% to Rs. 869 million in Q3FY19, sources declared.
The third quarter has traditionally been a low season due to festival holidays, however, this year, it registered a good performance, both in the hospitals and in the pharmacy division. The performance is primarily driven by a healthy result from the Mature hospitals, which reported revenue growth of 14%, and were able to significantly accelerate revenue growth vis-à-vis volume growth. This performance is a reinforcement of strategy for these hospitals, of focusing on COEs, higher quality of case mix and value pricing. Mature hospitals EBITDA margins have improved to 21.8% this quarter, well on the way to the 23% target over the next few quarters, sources said.
Dr Prathap C Reddy, Chairman, Apollo Hospitals Enterprise Ltd. (AHEL) said, “We are proud to announce the launch of our Proton Cancer Centre, an advanced technology for radiotherapy, first of its kind in South east Asia. Our investment in Proton re-affirms our commitment of putting the patient first, leveraging new technologies and elevating health outcomes. This also adds to our armoury in our ongoing and committed war against NCDs. We have launched a comprehensive 3-year preventive health and wellness program, which will be a definitive step in elevating the state of health in our workforce and communities. We also announced our foray into Kerala, with an operations management contract for a 250 bed super-speciality hospital in Cochin. This would help bolstering our Pan-India presence and provide us opportunities to increase our Medical Value Travel offerings to International patients. We are pleased that the quarter gone by was encouraging for Apollo Hospitals and we achieved notable progress on various operational and financial parameters.”